Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
VT-3989 by Vivace Therapeutics for Solid Tumor: Likelihood of Approval
VT-3989 is under clinical development by Vivace Therapeutics and currently in Phase II for Solid Tumor. According to GlobalData, Phase...
Data Insights
VT-3989 by Vivace Therapeutics for Malignant Pleural Mesothelioma: Likelihood of Approval
VT-3989 is under clinical development by Vivace Therapeutics and currently in Phase II for Malignant Pleural Mesothelioma. According to GlobalData,...